AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR

被引:95
作者
Welch, WJ [1 ]
Wilcox, CS [1 ]
机构
[1] Georgetown Univ, Med Ctr, Div Nephrol & Hypertens, Washington, DC 20007 USA
关键词
oxygen radicals; reactive oxygen species; tubuloglomerular feedback; hypertension; glomerular filtration rate; tempol; 7-nitroindazole; candesartan;
D O I
10.1046/j.1523-1755.2001.0590041257.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The tubuloglomerular feedback (TGF) responses of the spontaneously hypertensive rat (SHR) are under exaggerated regulation by angiotensin II (Ang II) type 1 receptors (AT(1)-R). Since AT(1)-Rs enhance oxy gen radical (O-2(-)) generation, we tested the hypothesis that the exaggerated TGF was due to a diminished blunting by macula dense (MD)-derived nitric oxide (NO) because of excessive AT(1)-R-dependent generation of O-2(-) Groups Of SHR and control Wistar-Kyoto (WKY) rats received vehicle (Veh), the AT1-R antagonist candesartan (Cand; 3 mg kg(-1) day-l), or nonspecific therapy with hydralazine + hydrochlorothiazide + reserpine (HHR) for two weeks. Compared with WKY rats, the elevated mean arterial pressure of SHR (WKY 125 +/- 2 vs. SHR 163 to 779 mm Hg, P < 0.001) was reduced (P < 0.001) similarly in SHR by Cand and HHR (121 +/- 5 and 116 +/- 5 mm Hg, P = NS). The SHR had an increased maximal TGF response (change in stop flow pressure during luminal perfusion of fluid: SHR 11.2 +/- 0.5 vs. WKY 8.3 +/- 0.4 mm Hg, P < 0.01) and a reduced TGF response to blockade of neuro-neal NO synthase (nNOS) in the MD with luminal 7-nitro-indazole (7-NI: Delta TGF in WKY 2.8 +/- 0.4 vs. SHR 1.1 +/- 0.6 mm Hg, P < 0.05). Although the elevated TGF responses of SHR were normalized by both HHR and Cand, only Cand restored a normal TGF response to luminal perfusion of the MD with 7-NI (Delta TGF with 7-NI in SHR: Veh + 1.8 +/- 0.4 vs. Cand + 3.4 +/- 0.5 mm Hg, P < 0.05). To abrogate the local effects of O-2(-), tempol (a membrane-permeable superoxide dismutase mimetic) was perfused into the efferent arteriole. During tempol, SHR given vehicle or HHR had a much increased response to blockade of nNOS with 7-NI (Delta TGF in SHR with 7-NI during tempol: Veh 6.3 +/- 1.0 and HHR 4.5 +/- 0.8 mm Hg, P < 0.01 vs. no tempol for both), implying that the effects of NO had been prevented because of excessive O-2(-) In contrast, the TGF response to 7-NI in SHR given Cand was unaffected by tempol (Delta TGF with 7-NI during tempol: 2.9 +/- 0.9, P = NS, compared with no tempol). In conclusion, TGF responses of SHR are exaggerated because of the effects of hypertension and AT1-R. AT1-R blockade specifically diminishes oxidative stress and restores NO signaling in the juxtaglomerular apparatus of the SHR.
引用
收藏
页码:1257 / 1263
页数:7
相关论文
共 37 条
[1]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[2]   Immunohistochemical colocalization of the alpha-subunit of neutrophil NADPH oxidase and ecto-5'-nucleotidase in kidney and liver [J].
Bachmann, S ;
Ramasubbu, K .
KIDNEY INTERNATIONAL, 1997, 51 (02) :479-482
[3]   Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension [J].
Bosse, HM ;
Bachmann, S .
HYPERTENSION, 1997, 30 (04) :948-952
[4]   MODULATION OF TUBULOGLOMERULAR FEEDBACK BY ANGIOTENSIN-II TYPE-1 RECEPTORS DURING THE DEVELOPMENT OF GOLDBLATT HYPERTENSION [J].
BRAAM, B ;
NAVAR, LG ;
MITCHELL, KD .
HYPERTENSION, 1995, 25 (06) :1232-1237
[5]  
Brännström K, 1999, J AM SOC NEPHROL, V10, pS213
[6]   ANGIOTENSIN PEPTIDES IN SPONTANEOUSLY HYPERTENSIVE AND NORMOTENSIVE DONRYU RATS [J].
CAMPBELL, DJ ;
DUNCAN, AM ;
KLADIS, A ;
HARRAP, SB .
HYPERTENSION, 1995, 25 (05) :928-934
[7]   ANGIOTENSIN AND THROMBOXANE IN GENETICALLY HYPERTENSIVE RATS - RENAL BLOOD-FLOW AND RECEPTOR STUDIES [J].
CHATZIANTONIOU, C ;
ARENDSHORST, WJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (02) :F238-F247
[8]   ANGIOTENSIN RECEPTOR-SITES IN RENAL VASCULATURE OF RATS DEVELOPING GENETIC-HYPERTENSION [J].
CHATZIANTONIOU, C ;
ARENDSHORST, WJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (06) :F853-F862
[9]  
KOST CK, 1994, J PHARMACOL EXP THER, V269, P82
[10]  
LI P, 1989, J PHARMACOL EXP THER, V251, P909